Sources

References

Sources cited on this site, numbered as they appear in the text.

  1. Khadhouri S, et al. (IDENTIFY Study Group). The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study. BJU Int. 2021;128(4):440–450. doi:10.1111/bju.15483
  2. Tan WS, et al. (DETECT I trial collaborators). Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients. Eur Urol. 2018. doi:10.1016/j.eururo.2018.03.008
  3. Tan WS, Ahmad A, Feber A, et al.; DETECT I trial collaborators. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer. J Intern Med. 2019;285(4):436–445. doi:10.1111/joim.12868
  4. Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU Guideline. J Urol. 2020;204(4):778–786.
  5. Bokhorst LP, Zhu X, Bul M, Bangma CH, Schröder FH, Roobol MJ. Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial. BJU Int. 2012;110(11):1654–1660. doi:10.1111/j.1464-410X.2012.11481.x